23 October 2020 | News
Transmedic will represent joimax in Singapore, Hong Kong, the Philippines, and Indonesia
Image source: transmedic
joimax, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, has announced a new partnership with Transmedic Group, a top medical device distributor headquartered in Singapore. In this exclusive deal, Transmedic will represent joimax in Singapore, Hong Kong, the Philippines, and Indonesia.
The long-term partnership will provide a broader surgical choice for patients considering endoscopic minimally invasive spinal surgery in these markets. With recent advances in the field of endoscopic discectomy (ED), the procedure has the potential to supersede microdiscectomy (MD) as the gold standard of care in the management of lumbar disc disease, as the latest literature suggests.
“joimax is very much looking forward to working with Transmedic Group,” says joimax Founder and CEO Wolfgang Ries. “With the rising popularity of endoscopic approaches in the management of spinal diseases, we’re able to deliver the highest standard of patient care, strengthen our sales activities, and enter into another important partnership across APAC.”
Teo Kee Meng, managing director of Transmedic Group commented, “We’re very pleased to partner with joimax. With their technological advancements and use of new spinal access corridors, major prevention of spinal structure collateral damage is assured, allowing for significantly reduced complications and improved postoperative recovery times."